The Pharma Data

DECEMBER 12, 2020

Health care workers and nursing home residents and staff should get the initial shots, according to guidelines issued recently by a U.S. The nursing home industry applauded the approval. The association represents 14,000 nursing homes and assisted living facilities. ” Who is first in line to be vaccinated?

Vaccine 52

Vaccine FDA Approval FDA Nurses 52

The Pharma Data

MAY 15, 2021

Before turning this formula into a supplement, I made sure that it is: Are natural, sourced from local growers that let plants reach their full maturity and use no chemical treatments. The product is made here, in the USA, in our FDA approved and GMP certified facility, under sterile, strict and precise standards.

Production 52

Production Packaging Nurses FDA Approval 52

The Pharma Data

DECEMBER 11, 2020

Food and Drug Administration is expected to approve emergency use of Pfizer’s coronavirus vaccine as early as Saturday after its advisory panel cleared the way for the start of a national campaign to inoculate Americans and stem the spread of COVID-19. Doctors say this reflects India’s younger and leaner population.

Vaccine 52

Vaccine FDA Hospitals Doctors 52

The Pharma Data

MAY 16, 2021

Before turning this formula into a supplement, I made sure that it is: with ingredients sourced from local growers that let plants naturally reach their full maturity and use no chemical treatments. Every capsule is made here, in the USA, in our FDA approved and GMP certified facility, under sterile, strict and precise standards.

Production 52

Production Nurses FDA Approval Packaging 52

PLOS: DNA Science

JUNE 1, 2023

The newest FDA-approved gene therapy treats the severe, skin-peeling condition dystrophic epidermolysis bullosa (DEB). The gene treatment has been a long time coming, but it differs from the handful of other approved gene therapies: it isn’t a one-and-done. Earlier results were published in Nature Medicine.

FDA Approval 52

FDA Approval Therapies FDA Disease 52

The Pharma Data

JUNE 18, 2021

. “We are encouraged by these promising results, which indicate ibrutinib and venetoclax combined has the potential to serve as an important chemotherapy-free, fixed-duration treatment option for people living with CLL,” said Dr. Paolo Ghia , M.D., 95% irrespective of subsequent randomized treatment ( Wierda, ASH 2020 ).

Treatment 40

Treatment FDA FDA Approval Therapies 40

The Pharma Data

JANUARY 26, 2021

While the preliminary nature of Phase 2 results from COVID-19 neutralizing monoclonal antibodies may have limited acceptance of treatment, these Phase 3 data further strengthen the available evidence,” said Daniel Skovronsky, M.D., It remains under review by the FDA. It remains under review by the FDA.

Hospitals 52

Hospitals Treatment Long-Term Care Facilities Trials 52